Cargando…
Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma
BACKGROUND: The role of eosinophils in cancer is not yet completely understood, but patients with eosinophilia show a trend towards longer survival in several types of cancer, including melanoma. However, eosinophil count at initial diagnosis of metastatic melanoma does not predict survival. Since e...
Autores principales: | Krückel, Annika, Moreira, Alvaro, Fröhlich, Waltraud, Schuler, Gerold, Heinzerling, Lucie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407264/ https://www.ncbi.nlm.nih.gov/pubmed/30845981 http://dx.doi.org/10.1186/s12885-019-5384-z |
Ejemplares similares
-
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients
por: Kirchberger, Michael Constantin, et al.
Publicado: (2018) -
Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports
por: Schliep, Stefan, et al.
Publicado: (2018) -
Current Melanoma Treatments: Where Do We Stand?
por: Moreira, Alvaro, et al.
Publicado: (2021) -
Kutane Lymphome
por: Heinzerling, Lucie, et al.
Publicado: (2013) -
Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)
por: Wildner, Dane, et al.
Publicado: (2021)